Pfizer Pays $67.5M To End Investors' Pristiq Disclosure Row
Pfizer Inc. unit Wyeth Pharmaceuticals Inc. agreed Friday to pay $67.5 million to settle a class action in New York federal court brought by a group of investors who say the...To view the full article, register now.
Already a subscriber? Click here to view full article